Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
HUSQVARNA GROUP: INTERIM REPORT JANUARY - MARCH 2024PR Newswire
Volvo Cars reports 8 per cent increase in Q1 2024 core operating profit to SEK 6.8 billionPR Newswire
Air Liquide continues its trajectory with another solid quarter, combining sales growth, performance improvement and investment momentumBusiness Wire
EQS-News: AMAG Austria Metall AG: Challenging environment influences quarterly resultEQS Newswire
EQS-News: Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per shareEQS Newswire
u-blox reports its first quarter 2024 trading updateEQS Newswire
Elliptic Labs Shipping Its AI Software Platform on Lenovo’s Newest ThinkPad™ P Series Workstation LaptopsBusiness Wire
EQS-Adhoc: Dexus Finance Pty Limited: Appointment of non-executive directorEQS Newswire
GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug DiscoveryPR Newswire
IMCD Spain expands its Pharmaceuticals presence with the acquisition of CobapharmaGlobeNewswire
Melexis Q1 2024 results – First quarter sales of 241.8 million EURGlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsGlobeNewswire
Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarterGlobeNewswire
WithSecuren osavuosikatsaus 1.1. – 31.3.2024: Elements-yhtiön kannattavuus kehittyy suotuisasti, huolimatta hitaasta vuoden aloituksestaGlobeNewswire
WithSecure Interim report 1 January – 31 March 2024: Elements Company profitability developing positively, despite slow start of the yearGlobeNewswire
Wereldhave Trading update Q1 2024GlobeNewswire
TGS Q1 2024 Presentation and WebcastGlobeNewswire
Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreGlobeNewswire
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023GlobeNewswire
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceGlobeNewswire
RNS announcements are delayed by up to an hour.
...